FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shoji Sanada

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Disorders

Physiology

Procedures

Myocardial Ischemic Preconditioning

Co-author Network

Publications

TOP 3
Hiroyuki Takahama; Masaki Yamato; Naoto Oku; Keiji Okuda; Shoji Sanada; Hirokazu Shigematsu; Tomohiro Asai; Masanori Asakura; Yoshihiro Asano; Hiroshi Asanuma; Hai Ying Fu; Masafumi Kitakaze; Issei Komuro; Takashi Matsuzaki; Tetsuo Minamino
Liposomal amiodarone augments anti-arrhythmic effects and reduces hemodynamic adverse effects in an ischemia/reperfusion rat model.
Akemi Yoshida; Masanori Asakura; Yoshihiro Asano; Hiroshi Asanuma; Tetsuo Minamino; Naoki Mochizuki; Hidezo Mori; Shoji Sanada; Motoaki Sano; Hideyuki Sasaki; Akito Shimouchi; Yoshiro Shinozaki; Masaru Sugimachi; Seiji Takashima; Satoru Yamazaki; Masafumi Kitakaze
H(2) mediates cardioprotection via involvements of K(ATP) channels and permeability transition pores of mitochondria in dogs.
Shoji Sanada; Kouki Ishii; Issei Komuro; Toshiki Moriyama; Makoto Nishida; Keiko Yamauchi-Takihara
Smoking promotes subclinical atherosclerosis in apparently healthy men: 2-year ultrasonographic follow-up.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shoji Sanada (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hiroyuki Takahama; Masaki Yamato; Naoto Oku; Keiji Okuda; Shoji Sanada; Hirokazu Shigematsu; Tomohiro Asai; Masanori Asakura; Yoshihiro Asano; Hiroshi Asanuma; Hai Ying Fu; Masafumi Kitakaze; Issei Komuro; Takashi Matsuzaki; Tetsuo Minamino
Liposomal amiodarone augments anti-arrhythmic effects and reduces hemodynamic adverse effects in an ischemia/reperfusion rat model.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2013;27(2):125-32.
2012: Akemi Yoshida; Masanori Asakura; Yoshihiro Asano; Hiroshi Asanuma; Tetsuo Minamino; Naoki Mochizuki; Hidezo Mori; Shoji Sanada; Motoaki Sano; Hideyuki Sasaki; Akito Shimouchi; Yoshiro Shinozaki; Masaru Sugimachi; Seiji Takashima; Satoru Yamazaki; Masafumi Kitakaze
H(2) mediates cardioprotection via involvements of K(ATP) channels and permeability transition pores of mitochondria in dogs.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2012;26(3):217-26.
2012: Shoji Sanada; Kouki Ishii; Issei Komuro; Toshiki Moriyama; Makoto Nishida; Keiko Yamauchi-Takihara
Smoking promotes subclinical atherosclerosis in apparently healthy men: 2-year ultrasonographic follow-up.
Circulation journal : official journal of the Japanese Circulation Society 2012;76(12):2884-91.
2012: Shoji Sanada; Masafumi Kitakaze; Issei Komuro
The less embraces the greater in detecting multiple coronary artery disease.
Circulation journal : official journal of the Japanese Circulation Society 2012;76(2):299-300.
2011: Shoji Sanada; Issei Komuro
Costarring statins with ARBs: going to be a smash hit?
Circulation journal : official journal of the Japanese Circulation Society 2011;75(3):540-1.
2010: Shoji Sanada; Masafumi Kitakaze
Combined renin-angiotensin system-inhibition therapy: what really accounts for the additive benefits?
Circulation journal : official journal of the Japanese Circulation Society 2010;74(11):2288-9.
2010: Hiroyuki Takahama; Hiroshi Asanuma; Shoji Sanada; Masashi Fujita; Hideyuki Sasaki; Masakatsu Wakeno; Jiyoong Kim; Masanori Asakura; Seiji Takashima; Tetsuo Minamino; Kazuo Komamura; Masaru Sugimachi; Masafumi Kitakaze
A histamine H₂ receptor blocker ameliorates development of heart failure in dogs independently of β-adrenergic receptor blockade.
Basic research in cardiology 2010;105(6):787-94.
2010: Hai Ying Fu; Ken-ichiro Okada; Yulin Liao; Osamu Tsukamoto; Tadashi Isomura; Mitsutoshi Asai; Tamaki Sawada; Keiji Okuda; Yoshihiro Asano; Shoji Sanada; Hiroshi Asanuma; Masanori Asakura; Seiji Takashima; Issei Komuro; Masafumi Kitakaze; Tetsuo Minamino
Ablation of C/EBP homologous protein attenuates endoplasmic reticulum-mediated apoptosis and cardiac dysfunction induced by pressure overload.
Circulation 2010;122(4):361-9.
2010: Tamaki Sawada; Tetsuo Minamino; Hai Ying Fu; Mitsutoshi Asai; Keiji Okuda; Tadashi Isomura; Satoru Yamazaki; Yoshihiro Asano; Ken-ichiro Okada; Osamu Tsukamoto; Shoji Sanada; Hiroshi Asanuma; Masanori Asakura; Seiji Takashima; Masafumi Kitakaze; Issei Komuro
X-box binding protein 1 regulates brain natriuretic peptide through a novel AP1/CRE-like element in cardiomyocytes.
Journal of molecular and cellular cardiology 2010;48(6):1280-9.
2009: Mahoto Kato; Shoji Sanada; Masafumi Kitakaze
Should we use outpatient dobutamine or milrinone?
Circulation. Heart failure 2009;2(4):377-8.
2009: Hideyuki Sasaki; Hiroshi Asanuma; Masashi Fujita; Hiroyuki Takahama; Masakatsu Wakeno; Shin Ito; Akiko Ogai; Masanori Asakura; Jiyoong Kim; Tetsuo Minamino; Seiji Takashima; Shoji Sanada; Masaru Sugimachi; Kazuo Komamura; Naoki Mochizuki; Masafumi Kitakaze
Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.
Circulation 2009;119(19):2568-77.
2008: Masashi Fujita; Masanori Asakura; Shoji Sanada; Hiroharu Funaya; Osamu Tsukamoto; Kazuo Komamura; Hiroshi Asanuma; Satoshi Taketani; Tadashi Isomura; Kenji Nakamaru; Hidehiko Furukawa; Yoshiki Sawa; Masatsugu Hori; Masafumi Kitakaze
Activation of ecto-5'-nucleotidase in the blood and hearts of patients with chronic heart failure.
Journal of cardiac failure 2008;14(5):426-30.
2007: Shoji Sanada; Hiroshi Asanuma; Yukihiro Koretsune; Kouki Watanabe; Shinsuke Nanto; Nobuhisa Awata; Noritake Hoki; Masatake Fukunami; Masafumi Kitakaze; Masatsugu Hori
Long-term oral administration of dipyridamole improves both cardiac and physical status in patients with mild to moderate chronic heart failure: a prospective open-randomized study.
Hypertension research : official journal of the Japanese Society of Hypertension 2007;30(10):913-9.
2007: Hiroshi Asanuma; Kunihiko Nakai; Shoji Sanada; Tetsuo Minamino; Seiji Takashima; Hisakazu Ogita; Masashi Fujita; Akio Hirata; Masakatsu Wakeno; Hiroyuki Takahama; Jiyoong Kim; Masanori Asakura; Ichiro Sakuma; Akira Kitabatake; Masatsugu Hori; Kazuo Komamura; Masafumi Kitakaze
S-nitrosylated and pegylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic hearts.
Journal of molecular and cellular cardiology 2007;42(5):924-30.
2006: Hiroshi Asanuma; Tetsuo Minamino; Akiko Ogai; Jiyoong Kim; Masanori Asakura; Kazuo Komamura; Shoji Sanada; Masashi Fujita; Akio Hirata; Masakatsu Wakeno; Osamu Tsukamoto; Yoshiro Shinozaki; Masafumi Myoishi; Seiji Takashima; Hitonobu Tomoike; Masafumi Kitakaze
Blockade of histamine H2 receptors protects the heart against ischemia and reperfusion injury in dogs.
Journal of molecular and cellular cardiology 2006;40(5):666-74.
2006: Osamu Tsukamoto; Tetsuo Minamino; Shoji Sanada; Ken-ichiro Okada; Akio Hirata; Masashi Fujita; Yasunori Shintani; Liao Yulin; Yoshihiro Asano; Seiji Takashima; Satoru Yamasaki; Hitonobu Tomoike; Masatsugu Hori; Masafumi Kitakaze
The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2006;20(2):93-102.
2005: Hiroshi Asanuma; Tetsuo Minamino; Shoji Sanada; Hisakazu Ogita; Jiyoong Kim; Masashi Fujita; Akio Hirata; Osamu Tsukamoto; Akiko Ogai; Koichi Node; Masatsugu Hori; Hitonobu Tomoike; Masafumi Kitakaze
A calcium channel blocker amlodipine increases coronary blood flow via both adenosine- and NO-dependent mechanisms in ischemic hearts.
Journal of molecular and cellular cardiology 2005;39(4):605-14.
2005: Masashi Fujita; Tetsuo Minamino; Hiroshi Asanuma; Shoji Sanada; Akio Hirata; Masakatsu Wakeno; Masafumi Myoishi; Hiroko Okuda; Akiko Ogai; Ken-ichiro Okada; Osamu Tsukamoto; Hidekazu Koyama; Masatsugu Hori; Masafumi Kitakaze
Aldosterone nongenomically worsens ischemia via protein kinase C-dependent pathways in hypoperfused canine hearts.
Hypertension 2005;46(1):113-7.
2005: Yan Li; Tetsuo Minamino; Osamu Tsukamoto; Toshiaki Yujiri; Yasunori Shintani; Ken-ichiro Okada; Yoko Nagamachi; Masashi Fujita; Akio Hirata; Shoji Sanada; Hiroshi Asanuma; Seiji Takashima; Masatsugu Hori; Gary L Johnson; Masafumi Kitakaze
Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model.
Circulation 2005;111(13):1672-8.
2005: Akio Hirata; Tetsuo Minamino; Hiroshi Asanuma; Shoji Sanada; Masashi Fujita; Osamu Tsukamoto; Masakatsu Wakeno; Masafumi Myoishi; Ken-Ichiro Okada; Hidekazu Koyama; Kazuo Komamura; Seiji Takashima; Yoshiro Shinozaki; Hidezo Mori; Hitonobu Tomoike; Masatsugu Hori; Masafumi Kitakaze
Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(1):33-40.
2004: Masashi Fujita; Tetsuo Minamino; Shoji Sanada; Hiroshi Asanuma; Akio Hirata; Hisakazu Ogita; Ken-ichiro Okada; Osamu Tsukamoto; Seiji Takashima; Hitonobu Tomoike; Koichi Node; Masatsugu Hori; Masafumi Kitakaze
Selective blockade of serotonin 5-HT2A receptor increases coronary blood flow via augmented cardiac nitric oxide release through 5-HT1B receptor in hypoperfused canine hearts.
Journal of molecular and cellular cardiology 2004;37(6):1219-23.
2004: Yasunori Shintani; Koichi Node; Hiroshi Asanuma; Shoji Sanada; Seiji Takashima; Yoshihiro Asano; Yulin Liao; Masashi Fujita; Akio Hirata; Yoshiro Shinozaki; Tomi Fukushima; Yoko Nagamachi; Hiroko Okuda; Jiyoong Kim; Hitonobu Tomoike; Masatsugu Hori; Masafumi Kitakaze
Opening of Ca2+-activated K+ channels is involved in ischemic preconditioning in canine hearts.
Journal of molecular and cellular cardiology 2004;37(6):1213-8.
2004: Shoji Sanada; Masafumi Kitakaze
Ischemic preconditioning: emerging evidence, controversy, and translational trials.
International journal of cardiology 2004;97(2):263-76.
2004: Shoji Sanada; Hiroshi Asanuma; Tetsuo Minamino; Koichi Node; Seiji Takashima; Hiroko Okuda; Yoshiro Shinozaki; Akiko Ogai; Masashi Fujita; Akio Hirata; Jiyoong Kim; Yoshihiro Asano; Hidezo Mori; Hitonobu Tomoike; Soichiro Kitamura; Masatsugu Hori; Masafumi Kitakaze
Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase.
Circulation 2004;110(15):2143-9.
2004: Yulin Liao; Masanori Asakura; Seiji Takashima; Akiko Ogai; Yoshihiro Asano; Yasunori Shintani; Tetsuo Minamino; Hiroshi Asanuma; Shoji Sanada; Jiyoong Kim; Soichiro Kitamura; Hitonobu Tomoike; Masatsugu Hori; Masafumi Kitakaze
Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Circulation 2004;110(6):692-9.
2004: Shoji Sanada; Hiroshi Asanuma; Osamu Tsukamoto; Tetsuo Minamino; Koichi Node; Seiji Takashima; Tomi Fukushima; Akiko Ogai; Yoshiro Shinozaki; Masashi Fujita; Akio Hirata; Hiroko Okuda; Hiroaki Shimokawa; Hitonobu Tomoike; Masatsugu Hori; Masafumi Kitakaze
Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C.
Circulation 2004;110(1):51-7.
2004: Hiroshi Asanuma; Tetsuo Minamino; Shoji Sanada; Seiji Takashima; Hisakazu Ogita; Akiko Ogai; Masanori Asakura; Yulin Liao; Yoshihiro Asano; Yasunori Shintani; Jiyoong Kim; Yoshiro Shinozaki; Hidezo Mori; Koichi Node; Soichiro Kitamura; Hitonobu Tomoike; Masatsugu Hori; Masafumi Kitakaze
Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
Circulation 2004;109(22):2773-9.
2004: Hisakazu Ogita; Koichi Node; Hiroshi Asanuma; Shoji Sanada; Jiyoong Kim; Seiji Takashima; Tetsuo Minamino; Masatsugu Hori; Masafumi Kitakaze
Raloxifene improves coronary perfusion, cardiac contractility, and myocardial metabolism in the ischemic heart: role of phosphatidylinositol 3-kinase/Akt pathway.
Journal of cardiovascular pharmacology 2004;43(6):821-9.
2004: Hiroshi Asanuma; Shoji Sanada; Akiko Ogai; Tetsuo Minamino; Seiji Takashima; Masanori Asakura; Hisakazu Ogita; Yoshiro Shinozaki; Hidezo Mori; Koichi Node; Hitonobu Tomoike; Masatsugu Hori; Masafumi Kitakaze
Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.
Journal of cardiovascular pharmacology 2004;43(4):574-9.
2004: Yoshihiro Asano; Seiji Takashima; Masanori Asakura; Yasunori Shintani; Yulin Liao; Tetsuo Minamino; Hiroshi Asanuma; Shoji Sanada; Jiyoong Kim; Akiko Ogai; Tomi Fukushima; Yumiko Oikawa; Yasushi Okazaki; Yasufumi Kaneda; Manabu Sato; Jun-ichi Miyazaki; Soichiro Kitamura; Hitonobu Tomoike; Masafumi Kitakaze; Masatsugu Hori
Lamr1 functional retroposon causes right ventricular dysplasia in mice.
Nature genetics 2004;36(2):123-30.
2004: Hisakazu Ogita; Koichi Node; Yulin Liao; Fuminobu Ishikura; Shintaro Beppu; Hiroshi Asanuma; Shoji Sanada; Seiji Takashima; Tetsuo Minamino; Masatsugu Hori; Masafumi Kitakaze
Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice.
Hypertension 2004;43(2):237-42.
2003: Yulin Liao; Seiji Takashima; Yoshihiro Asano; Masanori Asakura; Akiko Ogai; Yasunori Shintani; Tetsuo Minamino; Hiroshi Asanuma; Shoji Sanada; Jiyoong Kim; Hisakazu Ogita; Hitonobu Tomoike; Masatsugu Hori; Masafumi Kitakaze
Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model.
Circulation research 2003;93(8):759-66.
2003: Masanori Asakura; Seiji Takashima; Yoshihiro Asano; Tsuyoshi Honma; Hiroshi Asanuma; Shoji Sanada; Yasunori Shintani; Yulin Liao; Jiyoong Kim; Hisakazu Ogita; Koichi Node; Tetsuo Minamino; Ryosuke Yorikane; Akiko Agai; Soichiro Kitamura; Hitonobu Tomoike; Masatsugu Hori; Masafumi Kitakaze
Canine DNA array as a potential tool for combining physiology and molecular biology.
Circulation journal : official journal of the Japanese Circulation Society 2003;67(9):788-92.
2003: Hisakazu Ogita; Koichi Node; Hiroshi Asanuma; Shoji Sanada; Seiji Takashima; Tetsuo Minamino; Masaaki Soma; Jiyoong Kim; Masatsugu Hori; Masafumi Kitakaze
Eicosapentaenoic acid reduces myocardial injury induced by ischemia and reperfusion in rabbit hearts.
Journal of cardiovascular pharmacology 2003;41(6):964-9.
2003: Shoji Sanada; Masafumi Kitakaze
[Renin-angiotensin system as a potential target for the treatment with heart failure: ACE inhibitors, angiotensin-II receptor blockers and aldosterone antagonists].
Nihon rinsho. Japanese journal of clinical medicine 2003;61(5):821-6.
2003: Shoji Sanada; Masatsugu Hori; Koichi Node; Masafumi Kitakaze
[The trend of research on the mechanism of reperfusion injury].
Nihon rinsho. Japanese journal of clinical medicine 2003;61 Suppl 4():135-41.
2003: Hiroshi Asanuma; Koichi Node; Tetsuo Minamino; Shoji Sanada; Seiji Takashima; Yasunori Ueda; Yasuhiko Sakata; Masanori Asakura; Jiyoong Kim; Hisakazu Ogita; Michihiko Tada; Masatsugu Hori; Masafumi Kitakaze
Celiprolol increases coronary blood flow and reduces severity of myocardial ischemia via nitric oxide release.
Journal of cardiovascular pharmacology 2003;41(4):499-505.
2003: Shoji Sanada; Koichi Node; Tetsuo Minamino; Seiji Takashima; Akiko Ogai; Hiroshi Asanuma; Hisakazu Ogita; Yulin Liao; Masanori Asakura; Jiyoong Kim; Masatsugu Hori; Masafumi Kitakaze
Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats.
Hypertension 2003;41(4):963-7.
2003: Shoji Sanada; Koichi Node; Hiroshi Asanuma; Hisakazu Ogita; Seiji Takashima; Tetsuo Minamino; Masanori Asakura; Masatsugu Hori; Masafumi Kitakaze
[Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis].
Journal of cardiology 2003;41(1):43-4.
2002: Hisakazu Ogita; Koichi Node; Hiroshi Asanuma; Shoji Sanada; Yulin Liao; Seiji Takashima; Masanori Asakura; Hidezo Mori; Yoshiro Shinozaki; Masatsugu Hori; Masafumi Kitakaze
Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart.
Journal of the American College of Cardiology 2002;40(5):998-1005.
2002: Shoji Sanada; Koichi Node; Hiroshi Asanuma; Hisakazu Ogita; Seiji Takashima; Tetsuo Minamino; Masanori Asakura; Yulin Liao; Akiko Ogai; Jiyoong Kim; Masatsugu Hori; Masafumi Kitakaze
Opening of the adenosine triphosphate-sensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: role of 70-kDa S6 kinase and extracellular signal-regulated kinase.
Journal of the American College of Cardiology 2002;40(5):991-7.
2002: Masafumi Kitakaze; Hiroshi Asanuma; Hiroharu Funaya; Koichi Node; Seiji Takashima; Shoji Sanada; Masanori Asakura; Hisakazu Ogita; Jiyoong Kim; Masatsugu Hori
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin.
Journal of the American College of Cardiology 2002;40(1):162-6.
2002: Yulin Liao; Fuminobu Ishikura; Shintaro Beppu; Masanori Asakura; Seiji Takashima; Hiroshi Asanuma; Shoji Sanada; Jiyoon Kim; Hisakazu Ogita; Tsunehiko Kuzuya; Koichi Node; Masafumi Kitakaze; Masatsugu Hori
Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation.
American journal of physiology. Heart and circulatory physiology 2002;282(5):H1703-8.
2002: Seiji Takashima; Masafumi Kitakaze; Masanori Asakura; Hiroshi Asanuma; Shoji Sanada; Fumi Tashiro; Hitoshi Niwa; Jun-ichi Miyazaki Ji; Seiichi Hirota; Yukihiko Kitamura; Takashi Kitsukawa; Hajime Fujisawa; Michael Klagsbrun; Masatsugu Hori
Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(6):3657-62.
2002: Masanori Asakura; Masafumi Kitakaze; Yasuhiko Sakata; Hiroshi Asanuma; Shoji Sanada; Jyonjoon Kim; Hisakazu Ogida; Yulin Liao; Koichi Node; Seiji Takashima; Michihiko Tada; Masatsugu Hori
Adenosine-induced cardiac gene expression of ischemic murine hearts revealed by cDNA array hybridization.
Circulation journal : official journal of the Japanese Circulation Society 2002;66(1):93-6.
2002: Hisakazu Ogita; Koichi Node; Hiroshi Asanuma; Shoji Sanada; Seiji Takashima; Masanori Asakura; Masafumi Kitakaze; Masatsugu Hori
[Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart].
Journal of cardiology 2002;39(1):55-6.
2002: Masanori Asakura; Masafumi Kitakaze; Seiji Takashima; Yulin Liao; Fuminobu Ishikura; Tsuyoshi Yoshinaka; Hiroshi Ohmoto; Koichi Node; Kohichiro Yoshino; Hiroshi Ishiguro; Hiroshi Asanuma; Shoji Sanada; Yasushi Matsumura; Hiroshi Takeda; Shintaro Beppu; Michihiko Tada; Masatsugu Hori; Shigeki Higashiyama
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
Nature medicine 2002;8(1):35-40.
2001: Hiroshi Asanuma; Masafumi Kitakaze; Hiroharu Funaya; S Takashima; Tetsuo Minamino; Koichi Node; Y Sakata; Masanori Asakura; Shoji Sanada; Yoshiro Shinozaki; Hidezo Mori; Tsunehiko Kuzuya; M Tada; Masatsugu Hori
Nifedipine limits infarct size via NO-dependent mechanisms in dogs.
Basic research in cardiology 2001;96(5):497-505.
2001: Shoji Sanada; Masafumi Kitakaze; Koichi Node; Seiji Takashima; Akiko Ogai; Hiroshi Asanuma; Yasushi Sakata; Masanori Asakura; Hisakazu Ogita; Yulin Liao; T Fukushima; J Yamada; Tetsuo Minamino; Tsunehiko Kuzuya; Masatsugu Hori
Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
Hypertension 2001;38(3):404-11.
2001: Masafumi Kitakaze; Koichi Node; Seiji Takashima; Hiroshi Asanuma; Masanori Asakura; Shoji Sanada; Yoshiro Shinozaki; Hidezo Mori; H Sato; Tsunehiko Kuzuya; Masatsugu Hori
Role of cellular acidosis in production of nitric oxide in canine ischemic myocardium.
Journal of molecular and cellular cardiology 2001;33(9):1727-37.
2001: Shoji Sanada; Masafumi Kitakaze; PJ Papst; Hiroshi Asanuma; Koichi Node; Seiji Takashima; Masanori Asakura; Hisakazu Ogita; Yulin Liao; Yasushi Sakata; Akiko Ogai; Tomi Fukushima; J Yamada; Yoshiro Shinozaki; Tsunehiko Kuzuya; Hidezo Mori; N Terada; Masatsugu Hori
Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase.
Circulation 2001;104(6):705-10.
2001: Masafumi Kitakaze; Masanori Asakura; Yasushi Sakata; Hiroshi Asanuma; Shoji Sanada; Tsunehiko Kuzuya; J Miyazaki; Seiji Takashima; Masatsugu Hori
cDNA array hybridization reveals cardiac gene expression in acute ischemic murine hearts.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2001;15(2):125-30.
2001: Shoji Sanada; Masafumi Kitakaze; PJ Papst; K Hatanaka; Hiroshi Asanuma; T Aki; Yoshiro Shinozaki; Hisakazu Ogita; Koichi Node; Seiji Takashima; Masanori Asakura; J Yamada; Tomi Fukushima; Akiko Ogai; Tsunehiko Kuzuya; Hidezo Mori; N Terada; Kenji Yoshida; Masatsugu Hori
Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart.
Circulation research 2001;88(2):175-80.
2001: Hiroshi Asanuma; Masafumi Kitakaze; Koichi Node; Seiji Takashima; Yasushi Sakata; Masanori Asakura; Shoji Sanada; Yoshiro Shinozaki; Hidezo Mori; M Tada; Tsunehiko Kuzuya; Masatsugu Hori
Benidipine, a long-acting Ca channel blocker, limits infarct size via bradykinin- and NO-dependent mechanisms in canine hearts.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2001;15(3):225-31.
2001: Shoji Sanada; Masafumi Kitakaze; Hiroshi Asanuma; K Harada; Hisakazu Ogita; Koichi Node; Seiji Takashima; Yasushi Sakata; Masanori Asakura; Yoshiro Shinozaki; Hidezo Mori; Tsunehiko Kuzuya; Masatsugu Hori
Role of mitochondrial and sarcolemmal K(ATP) channels in ischemic preconditioning of the canine heart.
American journal of physiology. Heart and circulatory physiology 2001;280(1):H256-63.
2000: Masafumi Kitakaze; Koichi Node; Hiroshi Asanuma; Seiji Takashima; Y Sakata; Masanori Asakura; Shoji Sanada; Yoshiro Shinozaki; Hidezo Mori; Tsunehiko Kuzuya; Masatsugu Hori
Protein tyrosine kinase is not involved in the infarct size-limiting effect of ischemic preconditioning in canine hearts.
Circulation research 2000;87(4):303-8.
2000: Masafumi Kitakaze; Hiroshi Asanuma; Seiji Takashima; Tetsuo Minamino; Y Ueda; Yasushi Sakata; Masanori Asakura; Shoji Sanada; Tsunehiko Kuzuya; Masatsugu Hori
Nifedipine-induced coronary vasodilation in ischemic hearts is attributable to bradykinin- and NO-dependent mechanisms in dogs.
Circulation 2000;101(3):311-7.
1999: A D Blann; F Li-Saw-Hee; Gregory Y H Lip; Tetsuo Minamino; Masafumi Kitakaze; Shoji Sanada; Hiroshi Asanuma; Toshiya Kurotobi; Yukihiro Koretsune; Masatake Fukunami; Tsunehiko Kuzuya; Noritake Hoki; Masatsugu Hori
Increased membrane and soluble P-selectin in atrial fibrillation.
Circulation 1999;100(17):e86-7.
1999: Takahisa Yamada; Masatake Fukunami; Tsuyoshi Shimonagata; Kazuaki Kumagai; Shoji Sanada; Hisakazu Ogita; Y Asano; Masatsugu Hori; Noritake Hoki
Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation.
European heart journal 1999;20(3):211-20.
1998: Tetsuo Minamino; Masafumi Kitakaze; Shoji Sanada; H Asanuama; Toshiya Kurotobi; Yukihiro Koretsune; Masatake Fukunami; Tsunehiko Kuzuya; Noritake Hoki; Masatsugu Hori
Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide.
Circulation 1998;98(17):1721-7.
1998: Takahisa Yamada; Masatake Fukunami; Tsuyoshi Shimonagata; Kazuaki Kumagai; J Kim; Shoji Sanada; Hisakazu Ogita; Masatsugu Hori; Noritake Hoki
Prediction of the effectiveness of long-term beta blocker treatment for dilated cardiomyopathy by signal averaged electrocardiography.
Heart (British Cardiac Society) 1998;79(3):256-61.
1997: Y Abe; Masatake Fukunami; Takahisa Yamada; M Ohmori; Tsuyoshi Shimonagata; Kazuaki Kumagai; J Kim; Shoji Sanada; Masatsugu Hori; Noritake Hoki
Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography: a prospective study.
Circulation 1997;96(8):2612-6.
1996: Takahisa Yamada; Masatake Fukunami; Kazuaki Kumagai; Y Abe; J Kim; Shoji Sanada; Masatsugu Hori; T Kamada; Noritake Hoki
Detection of patients with sick sinus syndrome by use of low amplitude potentials early in filtered P wave.
Journal of the American College of Cardiology 1996;28(3):738-44.